BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

TIL

Instil Bio, Inc.
Nasdaq · Biological products, (no diagnostic substances) (SIC 2836) · FY ends 31 Dec

Revenue, quarterly

$0
$1$0
Q2 ’21Q3 ’21Q4 ’21
Company filings · 10-K filed 7 Mar 2022 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com

Cash and cash equivalents, quarter-end

$6M−27.9% year on year
$75M$50M$25M$0
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 13 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$56M
$100M$0−$100M−$200M−$300M
Q2 ’22Q1 ’23Q3 ’23Q2 ’24Q4 ’24
Company filings · 10-K filed 27 Mar 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty